HERBALIFE LTD.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $5.0B | $5.0B | $5.1B | $5.2B | $5.8B |
| Cost of revenue | $1.1B | $1.1B | $1.2B | $1.2B | $1.2B |
| Gross profit | $3.9B | $3.9B | $3.9B | $4.0B | $4.6B |
| Selling, general & administrative | — | $1.9B | $1.9B | $1.8B | $2.0B |
| Operating income | $481.0M | $385.9M | $356.4M | $545.2M | $734.1M |
| Interest expense | $214.4M | $218.3M | $165.9M | $139.3M | $153.1M |
| Pretax income | $275.1M | $169.4M | $203.0M | $424.8M | $560.8M |
| Income tax expense | $47.3M | -$84.9M | $60.8M | $103.5M | $113.6M |
| Net income | $228.3M | $254.3M | $142.2M | $321.3M | $447.2M |
| Balance Sheet | |||||
| Cash and equivalents | $353.1M | $415.3M | $575.2M | $508.0M | $601.5M |
| Current assets | $1.1B | $1.1B | $1.4B | $1.4B | $1.4B |
| Total assets | $2.8B | $2.7B | $2.8B | $2.7B | $2.8B |
| Current liabilities | $1.0B | $1.2B | $1.3B | $976.6M | $1.1B |
| Total liabilities | $3.3B | $3.5B | $3.9B | $4.0B | $4.2B |
| Total debt | $2.0B | $2.3B | $2.6B | $2.7B | $2.8B |
| Stockholders' equity | -$515.1M | -$801.1M | -$1.1B | -$1.3B | -$1.4B |
| Cash Flow Statement | |||||
| Cash from operations | $333.3M | $285.4M | $357.5M | $352.5M | $460.3M |
| Depreciation and amortization | $99.4M | $96.5M | $88.9M | $94.3M | $89.2M |
| Stock-based compensation | $44.1M | $50.0M | $48.0M | $44.4M | $54.1M |
| Capital expenditure | $80.4M | $122.0M | $135.0M | $156.4M | $151.4M |
| Free cash flow | $252.9M | $163.4M | $222.5M | $196.1M | $308.9M |
| Share repurchases | $8.2M | $8.3M | $11.0M | $146.7M | $1.0B |
Shares outstanding 103.7M · Free float 77.6%
Annual filing data through FY ended December 31, 2025; float as of July 12, 2026.